All in one visual acuity system
Indian Health Service · Crownpoint, NM
Why this score
ISBEE set-aside; but posted 579 days ago.
Solicitation # S-167761Updated Nov 13, 2025
This RFP closed on Dec 5, 2025.
Dec 5, 2025
Responses were due Dec 5, 2025, 5:00 PM MST
Same NAICS group or Healthcare & Medical, nearby first, ranked by score.
Indian Health Service · Crownpoint, NM
Why this score
ISBEE set-aside; but posted 579 days ago.
Indian Health Service · Crownpoint, NM
Why this score
New this week, 13 days to respond; but limited documentation.
Indian Health Service · Santa Fe, NM
Why this score
ISBEE set-aside, new this week; but small typical award (~$160K).
Indian Health Service · Santa Fe, NM
Why this score
ISBEE set-aside, new this week; but small typical award (~$160K).
Indian Health Service · Zuni, NM
Why this score
ISBEE set-aside, new this week; but small typical award (~$88K).
Indian Health Service · Santa Fe, NM
Why this score
New this week, ISBEE set-aside; but small typical award (~$129K).
RFP Detector Scores are informational.How we score →
Summary by RFP Detector
Department of Energy (Triad - DOE Contractor) posted a special notice titled “TECHNOLOGY LICENSING OPPORTUNITY: AirWave” under solicitation number S-167761. It was posted on Nov 13, 2025. The response deadline was Dec 5, 2025, 5:00 PM MST. It is classified under NAICS 339113 (Surgical Appliance and Supplies Manufacturing) and product/service code 1240. No set-aside is listed. The place of performance is Los Alamos, New Mexico. The listed point of contact is Satya Srinivasan.
Score at publication
Every RFP starts at 50. Each factor adds or subtracts points compared with a typical RFP; unknown data counts as neutral.
Frozen at publication: closed RFPs are not re-scored.
Starts at 50
No value published, and there isn't enough award history to estimate one. Scored as neutral.
Full and open competition.
83 other RFPs from Department of Energy on RFP Detector in the past 12 months; no award history found.
Special notice: 22 days to respond (due Dec 5, 2025, 5:00 PM MST).
Documents not listed, 2 named contacts with email, 579-word description.
Posted today.
50 + contributions = 67 (B, Strong)
Informational, not advice to bid or not bid. Score version 1.0.0, evaluated Nov 13, 2025.
Eligibility · Full and open competition
Full and open competition means the notice states no set-aside: any responsible business can respond, subject to the requirements in the notice.
Not stated in a form we could extract. See the official solicitation for requirements, evaluation criteria and submission steps.
From the official notice
The AirWave technology uses gentle sound vibrations, tuned to each person’s lungs, to shake loose stubborn mucus that makes breathing difficult. Unlike current methods, it can target problem spots deep in the airways with precision, offering a faster and more effective way to help patients with conditions like COVID-19, pneumonia, or chronic lung disease breathe easier. It’s a personalized, non-invasive solution with strong potential for hospitals and respiratory care. How it Works This technology uses sound waves to gently vibrate the lungs and airways, helping loosen and clear mucus that makes breathing difficult. What makes it unique is the ability to tune these sound waves specifically for each patient: A CT scan of the lungs is used to build a model of the patient’s airway structure. Computer modeling determines the exact sound frequencies that will produce the strongest vibrations in problem areas. The selected frequencies are then applied either through the mouth (using acoustic waves) or from outside the body (using devices like speakers or transducers). These targeted vibrations “shake loose” mucus deep inside the lungs, making it easier to clear and improving airflow. This personalized approach makes the therapy more effective, more comfortable, and adaptable for a wide range of respiratory conditions. Key Advantages Patient-specific customization – CT scans and modeling allow vibration frequencies to be tailored to each person’s lung anatomy. Targeted therapy – Specific problem areas in the lungs can be precisely reached, improving effectiveness where it’s most needed. Higher efficiency – Uses higher-frequency sound waves than current methods, producing stronger airway vibrations to loosen mucus more effectively. Non-invasive approach – Delivers therapy without surgical procedures or invasive devices. Multiple delivery methods – Can be applied through the mouth or externally using acoustic transducers, speakers, or shakers. Improved patient outcomes – Helps clear mucus faster, eases breathing, and reduces complications from respiratory illnesses. Broad clinical applications – Useful for conditions like COVID-19, pneumonia, and chronic lung diseases, making it valuable across healthcare settings. Commercial potential – Scalable solution for hospitals and respiratory care providers worldwide Market Applications Hospitals and healthcare systems – For treating patients with pneumonia, COVID-19, COPD, cystic fibrosis, and other respiratory conditions. Medical device manufacturers – Companies developing respiratory care devices (ventilators, airway clearance systems, acoustic or vibration-based therapies). Pulmonary rehabilitation centers – Clinics specializing in long-term care for patients with chronic lung diseases. Home healthcare providers – Potential adaptation for at-home respiratory therapy, especially for chronic conditions. Critical care and emergency medicine – Integration into ICUs and ERs to assist patients with severe breathing difficulties. Telehealth and remote monitoring companies – Future integration with connected respiratory care solutions for patient monitoring. Pharmaceutical and biotech firms – As a complementary therapy alongside respiratory drugs or inhaled treatments. Military and government health agencies – For treating respiratory distress in high-risk environments or pandemic response. Development Status: TRL 3 Patent pending LA-UR-25-30102 LANL Tech Partnerships: Unlock the Innovative Potential Los Alamos National Laboratory offers a wide range of cutting-edge technologies and capabilities that may provide your company with a competitive edge in the market and unlock the innovative potential that can enhance, refine, and revolutionize your products. LANL’s licensing program focuses on moving inventions developed by our researchers to commercial innovations. Patented and patent pending inventions and copyrighted software are available to existing and start-up companies through exclusive and non-exclusive licensing agreements. For specific discussions, please contact licensing@lanl.gov. Note: This is not a call for external services for the development of this technology. https://www.lanl.gov/engage/collaboration/feynman-center/partner-with-us/licensing-technology https://www.lanl.gov/engage/collaboration/feynman-center/tech-and-capability-search
No documents are listed for this notice.
Satya Srinivasan
PrimaryLindsay Augustyn
Points of contact as published on the notice.
Special Notice posted
Responses were due
139 open RFPs from this issuer and its offices.
Department of Energy
Why this score
New this week, active market ($3.8B FY24–FY26); but only 1 day left.
Department of Energy · Oak Ridge, TN
Why this score
New this week, active market ($440M FY24–FY26); but only 2 days left.
Department of Energy · New York
Why this score
Clear, complete notice, recently updated; but only 2 days left.
Why this score
Recently updated, active market ($207M FY24–FY26); but only 2 days left.
Why this score
New this week; but only 2 days left.
Department of Energy
Why this score
Small-business set-aside; but limited award history ($2.5M FY24–FY26).
RFP Detector Scores are informational.How we score →
Official federal notice. Updated Nov 13, 2025.
Official solicitation:Sign in free to open the official solicitation
RFP Detector is an independent service and is not affiliated with any government agency. Scores are informational.
RFP Detector is not affiliated with the organization that issued this RFP. Always rely on the official notice and confirm every date and requirement with the issuer.